Interferon beta, a group of widely-prescribed drugs for treating multiple sclerosis (MS), may not slow long-term progression of the disease, according to a new study of patients with relapsing-remitting MS that is due to be published this week in the Journal of the American Medical Association, JAMA...
via Featured Health News from Medical News Today Read More Here..
No comments:
Post a Comment